FDA approves a second Alzheimer's drug that can modestly slow disease – NPR
Business News
- FDA approves a second Alzheimer’s drug that can modestly slow disease NPR
- FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease CNN
- Approval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment The Wall Street Journal
- Alzhiemer’s drug Kisunla from Eli Lilly gains FDA approval USA TODAY
- FDA approves Eli Lilly’s Alzheimer’s drug that slows memory decline NBC News
Source: Business News